Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 198 (TMEM198) is a seven-transmembrane protein located at the plasma membrane and in cytoplasmic vesicles. It acts as a membrane scaffold, directly associating with the coreceptor LRP6 to recruit casein kinase family proteins, which is critical for phosphorylation of LRP6 and effective activation of Wnt/β-catenin signaling. TMEM198 is indispensable for both basal and casein kinase 1-induced LRP6 phosphorylation, facilitating signal transduction upon Wnt stimulation. It is expressed broadly during embryogenesis and is essential for processes such as neural crest formation and antero-posterior patterning. While TMEM198 shows molecular associations with diseases like rectosigmoid cancer, there is currently no evidence supporting its use as a direct therapeutic target or as a biomarker in clinical practice[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 198 (TMEM198).